Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target

The novel coronavirus disease 2019 (COVID-19) pandemic is severely challenging the healthcare systems and economies of the world, which urgently demand vaccine and therapy development to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, advancing our understanding of the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chekol Abebe, Endeshaw, Mengie Ayele, Teklie, Tilahun Muche, Zelalem, Asmamaw Dejenie, Tadesse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110213/
https://www.ncbi.nlm.nih.gov/pubmed/33986591
http://dx.doi.org/10.2147/BTT.S307352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110213/
https://www.ncbi.nlm.nih.gov/pubmed/33986591
http://dx.doi.org/10.2147/BTT.S307352

Ejemplares similares